Stress Hormone Pattern Flags PTSD Risk in Females

University of Cincinnati researchers identified a blood stress hormone pattern in female animal models that predicted later PTSD-like deficits.

Updated on Nov. 11, 2026 in Women’s Health

Photograph of a rack of unlabeled glass vials holding pale amber liquid on a steel laboratory bench in soft daylight.
University of Cincinnati researchers reported in Frontiers in Cellular Neuroscience that a stress hormone pattern in female animal models predicted later PTSD-like deficits. AI Illustration. Upload story photo >

Researchers at the University of Cincinnati reported in Frontiers in Cellular Neuroscience a stress hormone pattern that may signal PTSD vulnerability. In female animal models, stronger hormonal reactions to a mild stressor predicted PTSD-like deficits after a more intense stress exposure.

Why it matters

Women are diagnosed with PTSD at roughly twice the rate of men, making a potential biomarker of susceptibility relevant to women's mental health care. The findings are preclinical and do not yet establish a diagnostic test.

The study compared male and female animals, with females showing a predictive hormone pattern that males did not, against a backdrop in which women are diagnosed with PTSD at roughly twice the rate of men. Whether the same pattern holds in human trauma survivors remains untested.

The players

University of Cincinnati College of Medicine

The academic medical school of the University of Cincinnati, which conducted the preclinical research on stress hormones and PTSD susceptibility.

The details

Researchers exposed male and female animal models to a mild stressor and measured blood stress hormone levels. They then applied a more intense stress model to induce PTSD-like behavioral changes and tested anxiety, fear learning and fear extinction weeks later.

Timeline

  1. 2026: Study published in Frontiers in Cellular Neuroscience.

Health Landscape

The work extends preclinical research on corticosterone as a marker of PTSD-like behavior in rodent models, adding a sex-specific predictor for females. Its translation to clinical screening would depend on whether comparable hormone patterns emerge in women exposed to trauma.

At this stage the findings do not change how PTSD is diagnosed or treated for women. Any future stress-hormone screening would still require human clinical validation before reaching patient care.

The takeaway

Stress reactivity may matter differently by sex, a reminder that trauma research should account for female biology. Clinicians and patients should await human studies before expecting a biomarker test.

Further reading

Explore more in Women's Health for context on how sex differences shape trauma-related conditions.

Source note: This article includes information reported by Technology Networks.